Form 4: Ionis Pharmaceuticals Director Exercises Options and Sells Shares
SEC Form 4
Director Spencer R. Berthelsen exercised stock options and sold shares of Ionis Pharmaceuticals on June 17, 2024, according to a Form 4 filing.
Summary
- On June 17, 2024, Spencer R. Berthelsen, a director of Ionis Pharmaceuticals, exercised non-qualified stock options to acquire 16,000 shares of common stock at a price of $35.53 per share.
- Simultaneously, Berthelsen sold 16,000 shares of Ionis Pharmaceuticals common stock at a price of $40.29 per share.
- Following these transactions, Berthelsen directly owns 147,257 shares of Ionis Pharmaceuticals common stock.
- Berthelsen also disclaims beneficial ownership of 70 shares held by his daughter.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are a routine part of the stock market, providing transparency into the transactions of company insiders. These filings are closely watched by investors as they can provide insights into management's perspective on the company's stock and future prospects.
Key Dates
| Date | Description |
|---|---|
| 07/01/2015 | Date the Non-Qualified Stock Option became exercisable |
| 06/30/2024 | Expiration date of the Non-Qualified Stock Option |
| 06/17/2024 | Date of transaction: exercising options and selling shares |
| 06/18/2024 | Date of Form 4 signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.